2015
DOI: 10.1016/j.clineuro.2015.01.017
|View full text |Cite
|
Sign up to set email alerts
|

Modern management of paraclinoid aneurysms: Rise of flow diversion and fall of microsurgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…4) Consequently, endovascular techniques have been widely applied for the treatment of these cases with better results than those with microsurgical treatment. 5,6) In April 2011, the pipeline embolization device (PED) (Covidien, Irvine, CA, USA), which is a flow diversion (FD) device, was approved by the Food and Drug Administration for the treatment of large or giant wide-necked intracranial aneurysms of the proximal intracranial ICA, but not for those of the posterior communicating artery; the Japanese government approved the use of PED for the same indications in March 2015 in limited facilities. The efficacy of FD in the treatment of cerebral aneurysms has been established.…”
Section: Introductionmentioning
confidence: 99%
“…4) Consequently, endovascular techniques have been widely applied for the treatment of these cases with better results than those with microsurgical treatment. 5,6) In April 2011, the pipeline embolization device (PED) (Covidien, Irvine, CA, USA), which is a flow diversion (FD) device, was approved by the Food and Drug Administration for the treatment of large or giant wide-necked intracranial aneurysms of the proximal intracranial ICA, but not for those of the posterior communicating artery; the Japanese government approved the use of PED for the same indications in March 2015 in limited facilities. The efficacy of FD in the treatment of cerebral aneurysms has been established.…”
Section: Introductionmentioning
confidence: 99%
“…8,14 Since the publication of the International Subarachnoid Aneurysm Trial results, 15,16 the use of endovascular treatment for unruptured paraclinoid aneurysms has increased substantially, because of its low morbidity and mortality rates. 9,17,18 However, one issue that is encountered after endovascular treatment is aneurysm recanalization (AR). 9,17,19,20 To reduce the rate of AR and prevent aneurysm rupture, innovative endovascular treatments have been developed during recent decades, such as surface-modified coils, stent-assisted coiling, and flow diverters (FDs).…”
Section: Introductionmentioning
confidence: 99%